| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 53 | 2022 | 2601 | 7.210 |
Why?
|
| Magnetic Resonance Imaging | 52 | 2023 | 3362 | 6.010 |
Why?
|
| Neck | 11 | 2023 | 100 | 4.750 |
Why?
|
| Head and Neck Neoplasms | 11 | 2023 | 1052 | 3.900 |
Why?
|
| Temporal Bone | 9 | 2022 | 66 | 3.900 |
Why?
|
| Diagnostic Imaging | 14 | 2022 | 469 | 3.630 |
Why?
|
| Head | 10 | 2023 | 132 | 2.900 |
Why?
|
| Humans | 163 | 2023 | 86643 | 2.490 |
Why?
|
| Paranasal Sinus Diseases | 5 | 2016 | 25 | 2.480 |
Why?
|
| Parotid Gland | 4 | 2020 | 31 | 2.310 |
Why?
|
| Brain Neoplasms | 10 | 2019 | 763 | 2.250 |
Why?
|
| Paranasal Sinus Neoplasms | 3 | 2022 | 24 | 2.120 |
Why?
|
| Thermography | 3 | 2021 | 13 | 2.100 |
Why?
|
| Orbital Diseases | 4 | 2019 | 21 | 2.060 |
Why?
|
| Maxillary Sinus | 4 | 2016 | 26 | 2.020 |
Why?
|
| Choristoma | 3 | 2018 | 68 | 1.790 |
Why?
|
| Salivary Gland Neoplasms | 3 | 2018 | 66 | 1.680 |
Why?
|
| Neuroimaging | 3 | 2021 | 113 | 1.670 |
Why?
|
| Brain Diseases | 4 | 2019 | 180 | 1.610 |
Why?
|
| Nose Diseases | 3 | 2017 | 10 | 1.580 |
Why?
|
| Diagnosis, Differential | 21 | 2022 | 1565 | 1.570 |
Why?
|
| Male | 70 | 2022 | 40965 | 1.530 |
Why?
|
| Parotid Neoplasms | 2 | 2020 | 17 | 1.440 |
Why?
|
| Cysts | 3 | 2020 | 104 | 1.410 |
Why?
|
| Female | 68 | 2022 | 44532 | 1.410 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2023 | 43 | 1.410 |
Why?
|
| Cerebellum | 3 | 2023 | 247 | 1.400 |
Why?
|
| Hearing Loss, Conductive | 3 | 2019 | 17 | 1.390 |
Why?
|
| Glioblastoma | 4 | 2019 | 255 | 1.380 |
Why?
|
| Facial Nerve | 2 | 2019 | 33 | 1.360 |
Why?
|
| Oropharyngeal Neoplasms | 5 | 2022 | 118 | 1.350 |
Why?
|
| Eye Injuries | 2 | 2021 | 15 | 1.320 |
Why?
|
| Middle Aged | 47 | 2022 | 25028 | 1.300 |
Why?
|
| Stapes | 3 | 2019 | 8 | 1.300 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2022 | 138 | 1.290 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2020 | 1076 | 1.280 |
Why?
|
| Papillomavirus Infections | 5 | 2022 | 239 | 1.230 |
Why?
|
| Postoperative Complications | 8 | 2015 | 2207 | 1.220 |
Why?
|
| Foreign Bodies | 2 | 2022 | 63 | 1.220 |
Why?
|
| Larynx | 2 | 2017 | 38 | 1.160 |
Why?
|
| Barotrauma | 2 | 2016 | 5 | 1.160 |
Why?
|
| Intracranial Hemorrhages | 2 | 2019 | 120 | 1.150 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 381 | 1.120 |
Why?
|
| Meningioma | 5 | 2019 | 60 | 1.120 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2019 | 67 | 1.110 |
Why?
|
| Ossification, Heterotopic | 2 | 2016 | 31 | 1.110 |
Why?
|
| Skull Neoplasms | 3 | 2016 | 30 | 1.100 |
Why?
|
| Craniofacial Abnormalities | 2 | 2017 | 36 | 1.100 |
Why?
|
| Intestines | 3 | 2018 | 411 | 1.090 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2018 | 579 | 1.090 |
Why?
|
| Neurosurgical Procedures | 4 | 2018 | 213 | 1.060 |
Why?
|
| Tinnitus | 2 | 2016 | 21 | 1.060 |
Why?
|
| Face | 4 | 2013 | 114 | 1.050 |
Why?
|
| Adult | 42 | 2022 | 25648 | 1.050 |
Why?
|
| Cholangiography | 3 | 2011 | 41 | 1.040 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2018 | 99 | 1.010 |
Why?
|
| Stents | 5 | 2015 | 377 | 0.990 |
Why?
|
| Image Enhancement | 5 | 2019 | 563 | 0.990 |
Why?
|
| Nose | 2 | 2015 | 94 | 0.970 |
Why?
|
| Prosthesis-Related Infections | 3 | 2013 | 58 | 0.960 |
Why?
|
| Artifacts | 5 | 2022 | 244 | 0.950 |
Why?
|
| Astrocytoma | 2 | 2014 | 82 | 0.940 |
Why?
|
| Retrospective Studies | 20 | 2021 | 8489 | 0.930 |
Why?
|
| Bone Neoplasms | 4 | 2018 | 322 | 0.920 |
Why?
|
| Aged | 28 | 2021 | 18415 | 0.910 |
Why?
|
| Catheter Ablation | 4 | 2013 | 233 | 0.900 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2019 | 294 | 0.900 |
Why?
|
| Scleral Buckling | 2 | 2013 | 18 | 0.900 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 2 | 2013 | 31 | 0.890 |
Why?
|
| Foreign-Body Reaction | 2 | 2013 | 11 | 0.890 |
Why?
|
| Otosclerosis | 2 | 2022 | 6 | 0.890 |
Why?
|
| Brain | 6 | 2019 | 2216 | 0.880 |
Why?
|
| Foreign-Body Migration | 2 | 2013 | 35 | 0.870 |
Why?
|
| Hernia | 2 | 2014 | 23 | 0.860 |
Why?
|
| Cosmetic Techniques | 2 | 2012 | 28 | 0.860 |
Why?
|
| Rhinoplasty | 2 | 2013 | 34 | 0.860 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2014 | 262 | 0.850 |
Why?
|
| Thyroid Neoplasms | 3 | 2017 | 408 | 0.840 |
Why?
|
| Skull Base | 2 | 2013 | 47 | 0.840 |
Why?
|
| Orbit | 1 | 2022 | 37 | 0.830 |
Why?
|
| Neck Injuries | 1 | 2021 | 12 | 0.810 |
Why?
|
| Blast Injuries | 1 | 2021 | 11 | 0.810 |
Why?
|
| Ultrasonography | 6 | 2016 | 695 | 0.810 |
Why?
|
| Protons | 2 | 2021 | 98 | 0.800 |
Why?
|
| Lymphatic Metastasis | 2 | 2020 | 486 | 0.800 |
Why?
|
| Positron-Emission Tomography | 5 | 2022 | 329 | 0.790 |
Why?
|
| Paranasal Sinuses | 3 | 2017 | 60 | 0.790 |
Why?
|
| Ki-67 Antigen | 2 | 2019 | 64 | 0.780 |
Why?
|
| Biocompatible Materials | 2 | 2012 | 193 | 0.780 |
Why?
|
| Induction Chemotherapy | 3 | 2022 | 147 | 0.770 |
Why?
|
| Ephrin-A2 | 1 | 2020 | 3 | 0.760 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2020 | 16 | 0.760 |
Why?
|
| Papilloma, Inverted | 1 | 2020 | 6 | 0.750 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 115 | 0.750 |
Why?
|
| Edema | 3 | 2023 | 71 | 0.740 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 56 | 0.740 |
Why?
|
| Kidney Neoplasms | 3 | 2010 | 621 | 0.730 |
Why?
|
| Lymph Nodes | 3 | 2020 | 533 | 0.730 |
Why?
|
| Translocation, Genetic | 2 | 2018 | 265 | 0.730 |
Why?
|
| Fasciitis | 1 | 2019 | 10 | 0.710 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2020 | 100 | 0.710 |
Why?
|
| Nasal Cavity | 2 | 2017 | 91 | 0.710 |
Why?
|
| Embolization, Therapeutic | 3 | 2015 | 238 | 0.710 |
Why?
|
| Renal Artery | 2 | 2010 | 64 | 0.700 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2019 | 46 | 0.700 |
Why?
|
| Cholestasis | 2 | 2011 | 47 | 0.700 |
Why?
|
| Blood Volume | 3 | 2014 | 51 | 0.690 |
Why?
|
| Meningeal Neoplasms | 3 | 2019 | 61 | 0.680 |
Why?
|
| Migraine Disorders | 1 | 2019 | 40 | 0.680 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2018 | 9 | 0.680 |
Why?
|
| Catheterization | 2 | 2010 | 232 | 0.670 |
Why?
|
| Occipital Bone | 2 | 2016 | 18 | 0.670 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 546 | 0.670 |
Why?
|
| Microscopy | 1 | 2019 | 87 | 0.670 |
Why?
|
| Child | 13 | 2019 | 6927 | 0.670 |
Why?
|
| Capillary Permeability | 1 | 2019 | 130 | 0.660 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2018 | 2 | 0.660 |
Why?
|
| Maxillary Sinusitis | 2 | 2015 | 16 | 0.660 |
Why?
|
| Mouth Diseases | 1 | 2018 | 15 | 0.660 |
Why?
|
| Pamphlets | 1 | 2018 | 14 | 0.660 |
Why?
|
| Salivary Glands | 1 | 2018 | 18 | 0.650 |
Why?
|
| Osteosarcoma | 2 | 2018 | 158 | 0.650 |
Why?
|
| Aged, 80 and over | 13 | 2021 | 6509 | 0.650 |
Why?
|
| Histiocytosis, Sinus | 1 | 2018 | 14 | 0.650 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2017 | 62 | 0.650 |
Why?
|
| Infant | 8 | 2019 | 3046 | 0.650 |
Why?
|
| Pathology | 1 | 2018 | 30 | 0.640 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2019 | 1204 | 0.640 |
Why?
|
| Hearing Loss | 2 | 2016 | 56 | 0.630 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2018 | 51 | 0.630 |
Why?
|
| Granuloma, Pyogenic | 1 | 2017 | 5 | 0.630 |
Why?
|
| Stomach | 1 | 2018 | 108 | 0.620 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 86 | 0.620 |
Why?
|
| Epistaxis | 1 | 2017 | 19 | 0.620 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2017 | 28 | 0.610 |
Why?
|
| Nose Neoplasms | 1 | 2017 | 31 | 0.610 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 559 | 0.610 |
Why?
|
| Mammary Analogue Secretory Carcinoma | 1 | 2017 | 4 | 0.610 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2017 | 17 | 0.610 |
Why?
|
| Vestibule, Labyrinth | 2 | 2014 | 44 | 0.610 |
Why?
|
| Craniosynostoses | 1 | 2018 | 77 | 0.610 |
Why?
|
| Cartilage, Articular | 3 | 2009 | 67 | 0.610 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 1 | 2017 | 14 | 0.610 |
Why?
|
| Pleural Neoplasms | 2 | 2017 | 188 | 0.610 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 151 | 0.600 |
Why?
|
| Cartilage | 1 | 2017 | 113 | 0.600 |
Why?
|
| Sarcoidosis | 2 | 2015 | 71 | 0.600 |
Why?
|
| Health Literacy | 1 | 2018 | 70 | 0.600 |
Why?
|
| Breast Neoplasms | 4 | 2013 | 2903 | 0.590 |
Why?
|
| Semicircular Canals | 2 | 2016 | 30 | 0.590 |
Why?
|
| Thyroid Nodule | 3 | 2013 | 51 | 0.590 |
Why?
|
| Mandible | 1 | 2018 | 119 | 0.590 |
Why?
|
| Down Syndrome | 1 | 2017 | 53 | 0.580 |
Why?
|
| Laser Therapy | 1 | 2018 | 142 | 0.580 |
Why?
|
| Diagnostic Errors | 2 | 2015 | 160 | 0.580 |
Why?
|
| Rhabdoid Tumor | 1 | 2016 | 19 | 0.580 |
Why?
|
| Tongue Diseases | 1 | 2016 | 8 | 0.580 |
Why?
|
| Psychosurgery | 2 | 2013 | 13 | 0.570 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2016 | 10 | 0.570 |
Why?
|
| Pneumocephalus | 1 | 2016 | 10 | 0.570 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 387 | 0.560 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2016 | 4 | 0.560 |
Why?
|
| Intraoperative Care | 2 | 2014 | 82 | 0.560 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2016 | 2 | 0.560 |
Why?
|
| Encephalocele | 1 | 2016 | 24 | 0.560 |
Why?
|
| Trachea | 1 | 2017 | 293 | 0.560 |
Why?
|
| Tongue Neoplasms | 1 | 2016 | 50 | 0.550 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2020 | 93 | 0.550 |
Why?
|
| Leukoencephalopathies | 2 | 2015 | 15 | 0.550 |
Why?
|
| Ear Ossicles | 2 | 2015 | 10 | 0.550 |
Why?
|
| Vertigo | 1 | 2016 | 42 | 0.540 |
Why?
|
| Corpus Callosum | 2 | 2013 | 56 | 0.540 |
Why?
|
| Radiography, Interventional | 4 | 2010 | 150 | 0.540 |
Why?
|
| Retinal Hemorrhage | 1 | 2015 | 9 | 0.540 |
Why?
|
| Radiology | 1 | 2018 | 194 | 0.540 |
Why?
|
| Aspergillosis | 1 | 2016 | 41 | 0.540 |
Why?
|
| Cementoma | 1 | 2015 | 2 | 0.530 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2015 | 27 | 0.530 |
Why?
|
| Vertebral Artery | 2 | 2015 | 23 | 0.530 |
Why?
|
| Pharyngeal Diseases | 1 | 2015 | 11 | 0.530 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 329 | 0.530 |
Why?
|
| Odontogenic Tumors | 1 | 2015 | 11 | 0.530 |
Why?
|
| Headache | 1 | 2015 | 73 | 0.530 |
Why?
|
| Cranial Sinuses | 1 | 2015 | 15 | 0.530 |
Why?
|
| Mouth Neoplasms | 1 | 2017 | 194 | 0.530 |
Why?
|
| Laryngeal Diseases | 1 | 2015 | 20 | 0.530 |
Why?
|
| Eustachian Tube | 1 | 2015 | 9 | 0.530 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2015 | 19 | 0.530 |
Why?
|
| Mandibular Neoplasms | 1 | 2015 | 24 | 0.520 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2015 | 12 | 0.520 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2015 | 19 | 0.520 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2015 | 49 | 0.520 |
Why?
|
| Dacryocystorhinostomy | 1 | 2015 | 4 | 0.520 |
Why?
|
| Kidney Diseases | 2 | 2009 | 418 | 0.520 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 351 | 0.520 |
Why?
|
| Ear, External | 1 | 2015 | 26 | 0.520 |
Why?
|
| Polyps | 1 | 2015 | 28 | 0.520 |
Why?
|
| Eye Abnormalities | 1 | 2015 | 41 | 0.520 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2015 | 107 | 0.520 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 35 | 0.520 |
Why?
|
| Radiography | 6 | 2015 | 813 | 0.520 |
Why?
|
| Intubation | 1 | 2015 | 21 | 0.520 |
Why?
|
| Ultrasonography, Doppler | 3 | 2015 | 80 | 0.520 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2015 | 28 | 0.510 |
Why?
|
| Orbital Fractures | 1 | 2014 | 13 | 0.510 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2014 | 17 | 0.510 |
Why?
|
| Glioma | 2 | 2014 | 285 | 0.510 |
Why?
|
| Endoscopy | 2 | 2015 | 332 | 0.510 |
Why?
|
| Respiratory System Abnormalities | 1 | 2014 | 6 | 0.510 |
Why?
|
| Diverticulum | 1 | 2015 | 44 | 0.510 |
Why?
|
| Hyperostosis Frontalis Interna | 1 | 2014 | 5 | 0.510 |
Why?
|
| Joint Dislocations | 1 | 2014 | 27 | 0.500 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 81 | 0.500 |
Why?
|
| Emphysema | 1 | 2015 | 22 | 0.500 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.500 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2014 | 23 | 0.500 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 103 | 0.500 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 336 | 0.500 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1384 | 0.500 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 53 | 0.490 |
Why?
|
| Hematoma | 1 | 2015 | 104 | 0.490 |
Why?
|
| Cerebrovascular Circulation | 5 | 2015 | 212 | 0.490 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 1169 | 0.490 |
Why?
|
| Football | 1 | 2014 | 43 | 0.490 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 369 | 0.490 |
Why?
|
| Femur | 3 | 2016 | 116 | 0.490 |
Why?
|
| Sensitivity and Specificity | 7 | 2019 | 1991 | 0.480 |
Why?
|
| Hematoma, Subdural | 1 | 2013 | 23 | 0.480 |
Why?
|
| Vascular Neoplasms | 1 | 2013 | 19 | 0.480 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2013 | 1 | 0.480 |
Why?
|
| Skin | 1 | 2017 | 554 | 0.480 |
Why?
|
| Giant Cell Arteritis | 1 | 2013 | 5 | 0.480 |
Why?
|
| Neuroma, Acoustic | 2 | 2015 | 20 | 0.470 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2015 | 68 | 0.470 |
Why?
|
| Cerebellar Neoplasms | 1 | 2013 | 36 | 0.470 |
Why?
|
| Hyperplasia | 1 | 2013 | 148 | 0.470 |
Why?
|
| Facial Paralysis | 1 | 2013 | 17 | 0.470 |
Why?
|
| Paraproteinemias | 1 | 2013 | 13 | 0.470 |
Why?
|
| Treatment Outcome | 16 | 2022 | 7993 | 0.470 |
Why?
|
| Cerebral Revascularization | 1 | 2013 | 26 | 0.460 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 121 | 0.460 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2017 | 1313 | 0.460 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 232 | 0.460 |
Why?
|
| Hamartoma | 1 | 2013 | 31 | 0.450 |
Why?
|
| Cheek | 1 | 2013 | 22 | 0.450 |
Why?
|
| Immunohistochemistry | 5 | 2017 | 1753 | 0.450 |
Why?
|
| Paresthesia | 1 | 2013 | 16 | 0.450 |
Why?
|
| Dental Implants | 1 | 2013 | 10 | 0.450 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2012 | 6 | 0.450 |
Why?
|
| Malleus | 1 | 2012 | 4 | 0.440 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 162 | 0.440 |
Why?
|
| Adolescent | 11 | 2022 | 8981 | 0.430 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2012 | 48 | 0.430 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 143 | 0.430 |
Why?
|
| Ultrasonography, Mammary | 2 | 2009 | 82 | 0.420 |
Why?
|
| Contrast Media | 7 | 2013 | 1078 | 0.420 |
Why?
|
| Scalp | 1 | 2012 | 72 | 0.420 |
Why?
|
| Liver Transplantation | 2 | 2011 | 1268 | 0.420 |
Why?
|
| Frontal Lobe | 1 | 2012 | 130 | 0.410 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2020 | 466 | 0.410 |
Why?
|
| Brain Chemistry | 1 | 2012 | 121 | 0.410 |
Why?
|
| Organ Transplantation | 1 | 2015 | 265 | 0.410 |
Why?
|
| Prostatic Neoplasms | 2 | 2016 | 1721 | 0.410 |
Why?
|
| Hydrocephalus | 1 | 2012 | 101 | 0.410 |
Why?
|
| Quality Improvement | 1 | 2015 | 428 | 0.410 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2011 | 9 | 0.410 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2022 | 2438 | 0.400 |
Why?
|
| Papillomaviridae | 3 | 2022 | 153 | 0.400 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2011 | 5 | 0.400 |
Why?
|
| Biomarkers, Tumor | 4 | 2022 | 1464 | 0.400 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 456 | 0.400 |
Why?
|
| Cholangitis | 1 | 2011 | 19 | 0.390 |
Why?
|
| Infant, Newborn | 4 | 2018 | 2379 | 0.380 |
Why?
|
| Insufflation | 1 | 2010 | 10 | 0.380 |
Why?
|
| Dissection | 1 | 2010 | 42 | 0.370 |
Why?
|
| Carotid Arteries | 1 | 2011 | 127 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 407 | 0.370 |
Why?
|
| Papilloma, Intraductal | 1 | 2009 | 1 | 0.360 |
Why?
|
| Chylothorax | 1 | 2009 | 7 | 0.360 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 22 | 0.360 |
Why?
|
| Lymphography | 1 | 2009 | 27 | 0.360 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2009 | 31 | 0.360 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2010 | 80 | 0.350 |
Why?
|
| Gastrectomy | 1 | 2009 | 68 | 0.350 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2009 | 59 | 0.340 |
Why?
|
| Urologic Diseases | 1 | 2009 | 45 | 0.340 |
Why?
|
| Young Adult | 9 | 2022 | 5976 | 0.340 |
Why?
|
| Aneurysm, False | 1 | 2009 | 54 | 0.340 |
Why?
|
| Hepatic Artery | 1 | 2009 | 83 | 0.340 |
Why?
|
| Angioplasty, Balloon | 1 | 2009 | 95 | 0.340 |
Why?
|
| Esophagectomy | 1 | 2009 | 84 | 0.340 |
Why?
|
| Lipomatosis | 1 | 2008 | 9 | 0.330 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 231 | 0.330 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2008 | 5 | 0.330 |
Why?
|
| Venous Insufficiency | 1 | 2008 | 12 | 0.330 |
Why?
|
| Lithotripsy | 1 | 2008 | 41 | 0.330 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 11 | 0.330 |
Why?
|
| Healthy Volunteers | 2 | 2020 | 143 | 0.330 |
Why?
|
| Cholecystostomy | 1 | 2008 | 3 | 0.320 |
Why?
|
| Saphenous Vein | 1 | 2008 | 61 | 0.320 |
Why?
|
| Gallbladder Diseases | 1 | 2008 | 22 | 0.320 |
Why?
|
| Bile Ducts | 1 | 2008 | 59 | 0.320 |
Why?
|
| Gene Rearrangement | 2 | 2019 | 170 | 0.310 |
Why?
|
| Sepsis | 1 | 2011 | 306 | 0.300 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 148 | 0.300 |
Why?
|
| Child, Preschool | 5 | 2019 | 3612 | 0.290 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2009 | 208 | 0.290 |
Why?
|
| Radionuclide Imaging | 2 | 2021 | 220 | 0.290 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 321 | 0.290 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 329 | 0.290 |
Why?
|
| Biomarkers | 4 | 2019 | 1718 | 0.290 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2005 | 14 | 0.280 |
Why?
|
| Syndrome | 2 | 2018 | 446 | 0.280 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2008 | 237 | 0.270 |
Why?
|
| Humerus | 1 | 2005 | 31 | 0.270 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2017 | 96 | 0.270 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1673 | 0.270 |
Why?
|
| ROC Curve | 3 | 2019 | 752 | 0.270 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2017 | 128 | 0.270 |
Why?
|
| Fatal Outcome | 3 | 2017 | 293 | 0.260 |
Why?
|
| Audiometry | 2 | 2017 | 16 | 0.260 |
Why?
|
| Basilar Artery | 2 | 2015 | 41 | 0.260 |
Why?
|
| Chemoradiotherapy | 4 | 2022 | 301 | 0.260 |
Why?
|
| Rhombencephalon | 2 | 2015 | 50 | 0.250 |
Why?
|
| Rhinitis | 2 | 2017 | 175 | 0.240 |
Why?
|
| Four-Dimensional Computed Tomography | 2 | 2014 | 18 | 0.240 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 827 | 0.240 |
Why?
|
| Thyroid Gland | 2 | 2017 | 270 | 0.240 |
Why?
|
| Sinusitis | 2 | 2017 | 210 | 0.240 |
Why?
|
| Intracranial Aneurysm | 2 | 2015 | 158 | 0.240 |
Why?
|
| Decompression | 1 | 2023 | 3 | 0.230 |
Why?
|
| Prognosis | 5 | 2022 | 3679 | 0.230 |
Why?
|
| Electrocoagulation | 1 | 2023 | 22 | 0.230 |
Why?
|
| Gyrus Cinguli | 2 | 2013 | 45 | 0.230 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2015 | 663 | 0.220 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2011 | 102 | 0.220 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 849 | 0.220 |
Why?
|
| Pituitary Gland | 2 | 2013 | 117 | 0.220 |
Why?
|
| Kidney | 1 | 2008 | 1241 | 0.210 |
Why?
|
| Knee Joint | 2 | 2016 | 168 | 0.210 |
Why?
|
| Vision Disorders | 1 | 2022 | 75 | 0.200 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2022 | 62 | 0.200 |
Why?
|
| Craniotomy | 2 | 2012 | 88 | 0.200 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2013 | 38 | 0.200 |
Why?
|
| Drug Monitoring | 1 | 2022 | 118 | 0.200 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 180 | 0.200 |
Why?
|
| DNA, Viral | 1 | 2022 | 265 | 0.200 |
Why?
|
| Receptor, EphA2 | 1 | 2020 | 6 | 0.190 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2020 | 12 | 0.190 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2022 | 71 | 0.190 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 19 | 0.190 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2020 | 23 | 0.190 |
Why?
|
| Outpatients | 1 | 2021 | 94 | 0.190 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 318 | 0.190 |
Why?
|
| Emergencies | 1 | 2021 | 113 | 0.190 |
Why?
|
| Multiple Myeloma | 2 | 2017 | 307 | 0.190 |
Why?
|
| Nelson Syndrome | 1 | 2020 | 3 | 0.180 |
Why?
|
| Prolactinoma | 1 | 2020 | 8 | 0.180 |
Why?
|
| Head Injuries, Penetrating | 1 | 2020 | 54 | 0.180 |
Why?
|
| Gene Fusion | 1 | 2019 | 38 | 0.180 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2019 | 25 | 0.180 |
Why?
|
| Oval Window, Ear | 1 | 2019 | 3 | 0.180 |
Why?
|
| Anisotropy | 1 | 2019 | 62 | 0.180 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 71 | 0.170 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 88 | 0.170 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2019 | 63 | 0.170 |
Why?
|
| Organ Size | 1 | 2020 | 364 | 0.170 |
Why?
|
| Ear, Inner | 1 | 2019 | 33 | 0.170 |
Why?
|
| Cadaver | 1 | 2019 | 185 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2019 | 91 | 0.170 |
Why?
|
| Reference Values | 1 | 2020 | 674 | 0.170 |
Why?
|
| Salivary Gland Diseases | 1 | 2018 | 4 | 0.160 |
Why?
|
| Hip Prosthesis | 2 | 2009 | 34 | 0.160 |
Why?
|
| Neck Pain | 1 | 2018 | 17 | 0.160 |
Why?
|
| Carcinoma | 1 | 2022 | 436 | 0.160 |
Why?
|
| Neoplasm Staging | 3 | 2022 | 1939 | 0.160 |
Why?
|
| Ultrasonography, Interventional | 2 | 2009 | 121 | 0.160 |
Why?
|
| Multimodal Imaging | 2 | 2016 | 110 | 0.160 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 209 | 0.160 |
Why?
|
| Chronic Disease | 4 | 2017 | 971 | 0.160 |
Why?
|
| Tumor Burden | 1 | 2019 | 289 | 0.160 |
Why?
|
| Acute Disease | 1 | 2019 | 826 | 0.160 |
Why?
|
| Inpatients | 1 | 2021 | 297 | 0.160 |
Why?
|
| Joint Instability | 2 | 2009 | 81 | 0.160 |
Why?
|
| Nasal Septum | 1 | 2017 | 28 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 11 | 0.150 |
Why?
|
| Myoepithelioma | 1 | 2017 | 11 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2017 | 24 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2705 | 0.150 |
Why?
|
| Machine Learning | 1 | 2019 | 232 | 0.150 |
Why?
|
| Speech Reception Threshold Test | 1 | 2017 | 4 | 0.150 |
Why?
|
| ErbB Receptors | 1 | 2020 | 485 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 108 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 104 | 0.150 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 86 | 0.150 |
Why?
|
| Bone Malalignment | 1 | 2016 | 7 | 0.150 |
Why?
|
| Oropharynx | 1 | 2016 | 15 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 552 | 0.140 |
Why?
|
| Laryngoplasty | 1 | 2016 | 5 | 0.140 |
Why?
|
| Tectum Mesencephali | 1 | 2016 | 4 | 0.140 |
Why?
|
| Fibrosis | 1 | 2017 | 203 | 0.140 |
Why?
|
| Temperature | 1 | 2017 | 396 | 0.140 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2016 | 2 | 0.140 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 26 | 0.140 |
Why?
|
| Eikenella corrodens | 1 | 2015 | 2 | 0.140 |
Why?
|
| Chicago | 1 | 2021 | 1379 | 0.140 |
Why?
|
| Trismus | 1 | 2015 | 6 | 0.140 |
Why?
|
| Hypesthesia | 1 | 2015 | 15 | 0.140 |
Why?
|
| Leukocytosis | 1 | 2015 | 16 | 0.140 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 357 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2017 | 153 | 0.140 |
Why?
|
| Cochlear Implantation | 1 | 2016 | 31 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2020 | 395 | 0.140 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2015 | 23 | 0.140 |
Why?
|
| Chondrosarcoma | 1 | 2015 | 48 | 0.140 |
Why?
|
| Tachycardia | 1 | 2015 | 35 | 0.140 |
Why?
|
| Streptococcal Infections | 1 | 2015 | 57 | 0.130 |
Why?
|
| Patient Selection | 2 | 2009 | 685 | 0.130 |
Why?
|
| Fibroma, Ossifying | 1 | 2015 | 5 | 0.130 |
Why?
|
| Abscess | 1 | 2015 | 91 | 0.130 |
Why?
|
| Software | 1 | 2019 | 654 | 0.130 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 429 | 0.130 |
Why?
|
| Bone Diseases | 1 | 2015 | 54 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2016 | 397 | 0.130 |
Why?
|
| Age Factors | 1 | 2020 | 1851 | 0.130 |
Why?
|
| Workflow | 1 | 2015 | 77 | 0.130 |
Why?
|
| Fluoroscopy | 1 | 2015 | 119 | 0.130 |
Why?
|
| Laryngeal Neoplasms | 1 | 2015 | 89 | 0.130 |
Why?
|
| Disease Progression | 2 | 2017 | 1531 | 0.130 |
Why?
|
| Pyridines | 1 | 2017 | 310 | 0.130 |
Why?
|
| Fever | 1 | 2015 | 125 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 1197 | 0.130 |
Why?
|
| Rupture | 1 | 2014 | 63 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2022 | 4213 | 0.130 |
Why?
|
| Inflammation | 2 | 2017 | 920 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2021 | 2767 | 0.120 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2015 | 111 | 0.120 |
Why?
|
| Cerebral Angiography | 1 | 2015 | 196 | 0.120 |
Why?
|
| Magnetics | 1 | 2014 | 41 | 0.120 |
Why?
|
| Photons | 1 | 2014 | 46 | 0.120 |
Why?
|
| Osteitis | 1 | 2013 | 2 | 0.120 |
Why?
|
| Limbic System | 1 | 2013 | 23 | 0.120 |
Why?
|
| Facial Nerve Diseases | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2014 | 64 | 0.120 |
Why?
|
| Radiation Dosage | 1 | 2014 | 227 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 592 | 0.120 |
Why?
|
| Parathyroid Neoplasms | 1 | 2013 | 55 | 0.120 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 197 | 0.110 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2013 | 15 | 0.110 |
Why?
|
| Spine | 1 | 2013 | 102 | 0.110 |
Why?
|
| Injections, Intradermal | 1 | 2012 | 19 | 0.110 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 90 | 0.110 |
Why?
|
| Cranial Fossa, Middle | 1 | 2012 | 11 | 0.110 |
Why?
|
| Blood Volume Determination | 1 | 2012 | 14 | 0.110 |
Why?
|
| Cerebral Ventricles | 1 | 2012 | 76 | 0.110 |
Why?
|
| Pain | 1 | 2015 | 391 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2012 | 58 | 0.110 |
Why?
|
| Methemoglobin | 1 | 2012 | 8 | 0.110 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2012 | 8 | 0.110 |
Why?
|
| Lymphoma | 2 | 2013 | 262 | 0.110 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2012 | 13 | 0.110 |
Why?
|
| Melanins | 1 | 2012 | 23 | 0.110 |
Why?
|
| Minerals | 1 | 2012 | 22 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 3640 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2013 | 278 | 0.100 |
Why?
|
| Retinal Detachment | 1 | 2012 | 66 | 0.100 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 219 | 0.100 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2011 | 2 | 0.100 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2013 | 157 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2012 | 101 | 0.100 |
Why?
|
| Skull | 1 | 2013 | 249 | 0.100 |
Why?
|
| Amputees | 1 | 2011 | 6 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2012 | 238 | 0.100 |
Why?
|
| Bevacizumab | 1 | 2012 | 281 | 0.100 |
Why?
|
| Cardiovascular System | 1 | 2011 | 71 | 0.100 |
Why?
|
| Osteoarthritis, Hip | 1 | 2011 | 23 | 0.100 |
Why?
|
| Time Factors | 3 | 2013 | 5210 | 0.100 |
Why?
|
| Torque | 1 | 2010 | 10 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 724 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2014 | 574 | 0.090 |
Why?
|
| Plasmacytoma | 1 | 2010 | 34 | 0.090 |
Why?
|
| Incidence | 2 | 2015 | 1577 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 269 | 0.090 |
Why?
|
| Adrenalectomy | 1 | 2010 | 43 | 0.090 |
Why?
|
| Pregnancy | 1 | 2017 | 2894 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2501 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 449 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 1801 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 582 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2011 | 112 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 364 | 0.090 |
Why?
|
| Drainage | 1 | 2011 | 157 | 0.090 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2010 | 92 | 0.090 |
Why?
|
| Iohexol | 1 | 2009 | 26 | 0.090 |
Why?
|
| Exudates and Transudates | 1 | 2009 | 14 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 311 | 0.090 |
Why?
|
| Reoperation | 3 | 2008 | 597 | 0.090 |
Why?
|
| Contraindications | 1 | 2009 | 72 | 0.090 |
Why?
|
| Nipples | 1 | 2009 | 37 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2013 | 548 | 0.090 |
Why?
|
| Carboplatin | 2 | 2022 | 286 | 0.090 |
Why?
|
| Linear Models | 1 | 2010 | 421 | 0.090 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 1686 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2009 | 71 | 0.090 |
Why?
|
| Arthritis | 1 | 2009 | 46 | 0.090 |
Why?
|
| Prone Position | 1 | 2009 | 56 | 0.090 |
Why?
|
| Calcinosis | 1 | 2010 | 224 | 0.080 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2012 | 223 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2018 | 1004 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2009 | 111 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 213 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2360 | 0.080 |
Why?
|
| Paclitaxel | 2 | 2022 | 460 | 0.080 |
Why?
|
| Varicose Veins | 1 | 2008 | 10 | 0.080 |
Why?
|
| Sclerotherapy | 1 | 2008 | 16 | 0.080 |
Why?
|
| Phlebography | 1 | 2008 | 66 | 0.080 |
Why?
|
| Animals | 3 | 2014 | 26582 | 0.080 |
Why?
|
| Palliative Care | 1 | 2010 | 257 | 0.080 |
Why?
|
| Vascular Patency | 1 | 2008 | 126 | 0.080 |
Why?
|
| Acetabulum | 1 | 2008 | 28 | 0.080 |
Why?
|
| Leukemia | 1 | 2010 | 320 | 0.080 |
Why?
|
| Leg Length Inequality | 1 | 2007 | 2 | 0.080 |
Why?
|
| Anesthesia, Spinal | 1 | 2007 | 15 | 0.080 |
Why?
|
| Finger Joint | 1 | 2007 | 14 | 0.080 |
Why?
|
| Nephrectomy | 1 | 2010 | 294 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 746 | 0.080 |
Why?
|
| Length of Stay | 1 | 2011 | 702 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2008 | 285 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2011 | 710 | 0.080 |
Why?
|
| Hip Joint | 1 | 2007 | 55 | 0.080 |
Why?
|
| Hemoglobins | 1 | 2007 | 179 | 0.070 |
Why?
|
| Osteonecrosis | 1 | 2006 | 21 | 0.070 |
Why?
|
| Osteomyelitis | 1 | 2006 | 54 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 930 | 0.070 |
Why?
|
| Anesthesia, General | 1 | 2007 | 114 | 0.070 |
Why?
|
| Fibula | 1 | 2006 | 32 | 0.070 |
Why?
|
| Proteins | 1 | 2012 | 777 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2015 | 2261 | 0.070 |
Why?
|
| Mammography | 1 | 2009 | 463 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1830 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2007 | 166 | 0.070 |
Why?
|
| Elasticity | 1 | 2006 | 94 | 0.070 |
Why?
|
| Bone Transplantation | 1 | 2005 | 64 | 0.070 |
Why?
|
| Cattle | 1 | 2006 | 376 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2006 | 127 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2006 | 128 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2006 | 131 | 0.060 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 248 | 0.060 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 331 | 0.060 |
Why?
|
| Biomechanical Phenomena | 1 | 2006 | 457 | 0.060 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 45 | 0.050 |
Why?
|
| Sella Turcica | 1 | 2020 | 17 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2022 | 751 | 0.040 |
Why?
|
| Support Vector Machine | 1 | 2019 | 25 | 0.040 |
Why?
|
| Cisplatin | 1 | 2022 | 612 | 0.040 |
Why?
|
| Survivors | 1 | 2020 | 226 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2019 | 334 | 0.040 |
Why?
|
| Cetuximab | 1 | 2019 | 113 | 0.040 |
Why?
|
| Quality of Life | 2 | 2017 | 1585 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 1139 | 0.040 |
Why?
|
| Cartilage Diseases | 1 | 2016 | 16 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 27 | 0.040 |
Why?
|
| Rotation | 1 | 2016 | 89 | 0.040 |
Why?
|
| Knee Injuries | 1 | 2016 | 53 | 0.030 |
Why?
|
| Everolimus | 1 | 2016 | 40 | 0.030 |
Why?
|
| Vestibular Aqueduct | 1 | 2015 | 2 | 0.030 |
Why?
|
| Mastoid | 1 | 2015 | 17 | 0.030 |
Why?
|
| Internationality | 1 | 2015 | 69 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1961 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1863 | 0.030 |
Why?
|
| Nasal Mucosa | 1 | 2015 | 186 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2015 | 221 | 0.030 |
Why?
|
| Remission Induction | 1 | 2016 | 722 | 0.030 |
Why?
|
| Hyperparathyroidism | 1 | 2013 | 67 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 2262 | 0.030 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2013 | 25 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 86 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2013 | 303 | 0.030 |
Why?
|
| Behavior | 1 | 2013 | 85 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 594 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2013 | 195 | 0.020 |
Why?
|
| Pediatrics | 1 | 2015 | 344 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2013 | 161 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Hip Dislocation | 1 | 2009 | 10 | 0.020 |
Why?
|
| United States | 1 | 2022 | 6672 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1458 | 0.020 |
Why?
|
| Arthroscopy | 1 | 2009 | 94 | 0.020 |
Why?
|
| Ankylosis | 1 | 2007 | 4 | 0.020 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2007 | 13 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2007 | 121 | 0.020 |
Why?
|
| Hip Fractures | 1 | 2007 | 45 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2007 | 161 | 0.020 |
Why?
|